Yoo Na Lee, Ki Seong Ko, Jae Yong Yoo, Bich Ngoc Vu, Young Eun Lee, Ha Na Choi, Mi Hui Jang, Kyun Oh Lee
언어
영어(ENG)
URL
https://www.earticle.net/Article/A415468
※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.
원문정보
초록
영어
Gaucher's disease is a metabolic disorder in which a functional deficiency of an enzyme occurs due to a mutation in the gene encoding glucocerebrosidase (GC), resulting in multiple organ malfunctions. Gaucher's disease is being treated with enzyme replacement therapy, which compensates for the enzyme deficiency by administering activated GCs produced in mammalian cells. However, there is a potential of contamination by pathogenic viruses or prions in the mammalian cell-based manufacturing method, as well as a high production cost. In this study, GCs were expressed in plants that produce customized N-glycans to overcome the limitations of the mammalian cell-based production system and to produce a safe treatment drug for Gaucher's disease. A human cDNA library was used to clone a region expressing a GC gene, and sequence analysis was performed. In addition, a binary vector was created and introduced into plants using Agrobacterium to insert the sequence-confirmed GC gene. Plants into which the GC gene was introduced were selected using an antibiotic-containing media, and the presence or absence of the GC gene introduction into the transformed plants was confirmed using polymerase chain reaction (PCR). Furthermore, proteins were collected from the plant leaves into which the gene was inserted, and GC expression levels in the transformed plants were measured using a GC antibody. Finally, a single cloned plant was selected through the antibiotic-resistant isolate ratio. These findings suggest that employing plants, it is possible to overcome the disadvantages of the present mammalian cell-based manufacturing method, decreasing the production cost of pricey Gaucher's disease therapy, and effectively generating safer enzyme treatment.
저자
Yoo Na Lee [ Division of Applied Life Sciences (BK4 Program), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University ]
Ki Seong Ko [ Division of Applied Life Sciences (BK4 Program), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University ]
Jae Yong Yoo [ Division of Applied Life Sciences (BK4 Program), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University ]
Bich Ngoc Vu [ Division of Applied Life Sciences (BK4 Program), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University ]
Young Eun Lee [ Division of Applied Life Sciences (BK4 Program), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University ]
Ha Na Choi [ Division of Applied Life Sciences (BK4 Program), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University ]
Mi Hui Jang [ Division of Applied Life Sciences (BK4 Program), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University ]
Kyun Oh Lee [ Division of Applied Life Sciences (BK4 Program), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University ]
Corresponding Author
본 학회는 화학, 생화학, 분자생물학, 미생물학, 식품공학, 의학, 약학, 유전공학 및 생물공학, 환경 및 기타 공업 등 전 분야의 탄수화물관련 이론과 기술을 연구 발전시키고 산학협동을 통해 이를 보급하여 국내 관련 산업의 발전 및 국민생활의 과학화에 기여하고자 하며, 이러한 목표와 비젼의 실현을 위해 회원들이 적극적인 참여와 활동을 전개하고자 한다.